Cabaletta Bio, Inc. (CABA) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Cabaletta Bio reported revenue of $0. Net income was -$167.9M, or -$2.10 per diluted share. Operating activities generated -$131.1M of cash, leaving -$132.3M of free cash flow. At fiscal year end, Cabaletta Bio held $165.1M in total assets against $53.0M in total liabilities, including $83.0M of cash and equivalents.
Open the full interactive Cabaletta Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Cabaletta Bio Key Stats
| Share Price | $1.69 |
|---|---|
| Market Cap | $255.5M |
| 52-Week Range | $1.69 – $4.15 |
| Shares Outstanding | 151.2 million (basic, 2026 Q2) |
Cabaletta Bio Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$33.8M | -$46.3M | -$54.1M | -$74.7M | -$125.1M | -$172.2M |
| Pre-Tax Income | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$115.9M | -$167.9M |
| Income Tax | — | — | — | — | — | $0 |
| Net Income | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$115.9M | -$167.9M |
| Diluted EPS | -$1.44 | -$1.80 | -$1.81 | -$1.65 | -$2.34 | -$2.10 |
Cabaletta Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$44.9M | -$41.9M | -$43.5M | -$51.0M |
| Diluted EPS | -$0.44 | — | -$0.39 | -$0.34 |
Cabaletta Bio Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $101.4M | $122.2M | $81.6M | $193.2M | $164.0M | $83.0M |
| Current Assets | $113.5M | $124.5M | $108.8M | $244.5M | $166.7M | $138.9M |
| Total Assets | $114.7M | $126.3M | $117.0M | $253.7M | $185.0M | $165.1M |
| Current Liabilities | $5.2M | $8.4M | $9.5M | $16.0M | $27.1M | $50.2M |
| Total Liabilities | $5.2M | $8.4M | $12.4M | $17.5M | $32.7M | $53.0M |
| Shareholders' Equity | $109.5M | $118.0M | $104.5M | $236.2M | $152.3M | $112.1M |
Cabaletta Bio Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$26.8M | -$34.1M | -$46.4M | -$53.5M | -$88.2M | -$131.1M |
| Cash From Investing | -$8.0M | $6.0M | -$27.2M | -$22.5M | $47.3M | -$50.3M |
| Cash From Financing | -$24,000 | $48.9M | $33.0M | $187.6M | $11.7M | $100.3M |
| Free Cash Flow | -$27.4M | -$35.3M | -$48.8M | -$54.2M | -$90.4M | -$132.3M |
Figures from Cabaletta Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cabaletta Bio financials page for every line item.
Cabaletta Bio Company Profile
| Ticker | CABA |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Philadelphia, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001759138 |
Frequently Asked Questions
What was Cabaletta Bio's revenue in fiscal 2025?
Cabaletta Bio (CABA) reported revenue of $0 for fiscal 2025.
What is Cabaletta Bio's annual revenue history?
Cabaletta Bio's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Cabaletta Bio's net income in fiscal 2025?
Cabaletta Bio reported net income of -$167.9M for fiscal 2025.
What was Cabaletta Bio's earnings per share (EPS) in fiscal 2025?
Cabaletta Bio's diluted EPS was -$2.10 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cabaletta Bio generate in fiscal 2025?
Cabaletta Bio generated -$132.3M of free cash flow in fiscal 2025.
What was Cabaletta Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Cabaletta Bio reported revenue of $0.
How many shares of Cabaletta Bio are outstanding?
Cabaletta Bio reported a weighted average of 151.2 million basic shares outstanding in 2026 Q2.
What is Cabaletta Bio's market cap?
Based on its latest closing price, Cabaletta Bio (CABA) has a market capitalization of about $255.5M.
When does Cabaletta Bio's fiscal year end?
Cabaletta Bio's fiscal year end, as registered with the SEC, is December 31.
Where is Cabaletta Bio headquartered?
Cabaletta Bio lists its business address in Philadelphia, Pennsylvania in its SEC filings.
Cabaletta Bio Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →